Market Access News
Toronto, September 7, 2021 – MORSE Consulting is pleased to announce the addition of Katherine Scott as a Consultant. The Canadian public system remains one of the critical payers in this country’s pharmaceutical reimbursement pathway. This system is growing increasingly complex with new funding mechanisms for emerging gene and cell therapies, novel approaches related to outcomes-based agreements, evolving policies related to biosimilars, and variations in how provincial payers implement pCPA…
pan-Canadian Pharmaceutical Alliance (pCPA): July 2021 Trends and Insights July 2021 Highlights: 5 products completed CADTH review 5 products initiated pCPA negotiations 3 negotiations were completed with an LOI 1 negotiation was closed without an LOI 1 file was closed without negotiation Key Take-Aways: CADTH released no non-oncology recommendations in July. The volume of files under consideration remains relatively stable in July at 30, with no decrease in…
pan-Canadian Pharmaceutical Alliance (pCPA): June 2021 Trends and Insights June 2021 Highlights: 8 products completed CADTH review 12 products initiated pCPA negotiations 3 negotiations were completed with an LOI 0 negotiations were closed without an LOI 2 files were closed without negotiation Key Take-Aways: The volume of files under consideration remains stable with a slight decrease in the days under consideration in June relative to the last 6…
pan-Canadian Pharmaceutical Alliance (pCPA): May 2021 Trends and Insights May 2021 Highlights: 6 products completed CADTH review 3 products initiated pCPA negotiations 3 negotiations were completed with an LOI 1 negotiation was closed without an LOI 0 files were closed without negotiation Key Take-Aways: May sees continued consistency in both the volume of files under consideration and the average days under consideration which is hovering around the 5-month…
Author: Patrick Manfred, Vice-President, TACT Conseil, Quebec Market Access Expert Date: June 2, 2021 A proposal to modify the current regulation framing the fees payable to the Institut national d'excellence en santé (INESSS) to complete a scientific evaluation of a drug and/or a stable blood product was published in Part 2 of the Quebec Official Gazette, on March 18, 2021. If the Quebec government does not deviate from…
pan-Canadian Pharmaceutical Alliance (pCPA): April 2021 Trends and Insights April 2021 Highlights: 5 products completed CADTH review 6 products initiated pCPA negotiations 4 negotiations were completed with an LOI 1 negotiation was closed without an LOI 0 file was closed without negotiation Key Take-Aways: The volume of files under consideration has remained relatively high and stable for the last 5 months (27-30), although the ratio of oncology to…
Toronto, May 4th, 2021 – MORSE Consulting is pleased to release their 2021 edition of the Canadian Reimbursement and Forecasting Timelines (CRaFT) report - a comprehensive source of reimbursement timelines and insights to inform forecasting and planning needs. MORSE has analyzed Canadian market access data from 2018 through 2020 to produce key reimbursement metrics. The report will support forecasting or planning necessary for launch in Canadian by providing critical insights on the public…
pan-Canadian Pharmaceutical Alliance (pCPA): March 2021 Trends and Insights March 2021 Highlights: 5 products completed CADTH review 3 products initiated pCPA negotiations 2 negotiations were completed with an LOI 3 negotiations were closed without an LOI 0 files were closed without negotiation Key Take-Aways: The average duration that files are under consideration reaches an annual peak of ~160 days. In addition, the number of files under consideration matches…
pan-Canadian Pharmaceutical Alliance (pCPA): February 2021 Trends and Insights February 2021 Highlights: 5 products completed CADTH review 7 products initiated pCPA negotiations 6 negotiations were completed with an LOI 0 negotiations were closed without an LOI 1 file was closed without negotiation Files Under pCPA Consideration: CADTH issued 5 new recommendations in February (28 files under pCPA consideration as of Feb 28) – down from 29 in January.…
Introduction The Canadian Association for Healthcare Reimbursement (CAHR) held its virtual Western Day Conference on February 9th, 2021. Members of the MORSE team attended this conference and have prepared a brief summary of the key highlights. Disclaimer: Please note, this summary is based on our team’s interpretation of the discussion. This conference was dedicated to Steve Long, who passed away of cancer in 2019. He was a friend, mentor, and…
pan-Canadian Pharmaceutical Alliance (pCPA): January 2021 Trends and Insights January 2021 Highlights: 4 products completed CADTH review 9 products initiated pCPA negotiations 5 negotiations were completed with an LOI 0 negotiations were closed without an LOI 1 file was closed without negotiation Files Under pCPA Consideration: CADTH issued 4 new recommendations & notifications to implement in January (29 files under pCPA consideration as of January 31) – down from…
MORSE Consulting is pleased to release our Fourth Annual pCPA Year in Review Infographic – 2020 Edition. This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2020. This infographic compares year-over-year metrics including: pCPA activity summary; the effect of COVID-19 on under-consideration files; average time to complete a negotiation; and files adjudicated by the pCPA by type in 2020. This infographic is an excerpt…
pan-Canadian Pharmaceutical Alliance (pCPA): December 2020 Trends and Insights December 2020 Highlights: 8 products completed CADTH review 2 products initiated pCPA negotiations 4 negotiations were completed with an LOI 1 negotiation was closed without an LOI 0 files were closed without negotiation Beginning this month and over the next few months, the pCPA is introducing a Targeted Negotiation Process (TNP) to address selected files that have been on hold…
Happy Holidays from MORSE Consulting! As we enter the holiday season and the close of our fourth year of MORSE’s operations, we wish to share our gratitude to our community – our clients, strategic partners, and team members, for banding together and supporting each other through a challenging year. —
pan-Canadian Pharmaceutical Alliance (pCPA): November 2020 Trends and Insights November 2020 Highlights: 4 products completed CADTH review 8 products initiated pCPA negotiation 5 negotiations were completed with an LOI 0 negotiations were closed without an LOI 0 files were closed without negotiation Files Under pCPA Consideration: CADTH issued 4 new recommendations & notifications to implement in November (24 files under pCPA consideration as of November 30) – down…
Contact Us
MORSE Consulting Inc.
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
Browse our Market Access News section - Page 3 of 11 - MORSE Consulting Inc.
